Mylan Tries To Escape Pharmacy's EpiPen Antitrust Suit

By Meghan Kelly · December 15, 2020, 5:46 PM EST

Mylan Pharmaceuticals has urged a Kansas federal judge to drop it from a suit alleging it inflated the price for the emergency allergy medication EpiPen, arguing the retail and online pharmacy...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

In Re: Epipen (Epinephrine Injection, USP) Marketing, Sales Practices and Antitrust Litigation

Case Number

2:17-md-02785

Court

Kansas

Nature of Suit

Personal Inj. Prod. Liability

Date Filed

August 04, 2017

Case Title

KPH Healthcare Services, Inc. v. Mylan N.V. et al

Case Number

2:20-cv-02065

Court

Kansas

Nature of Suit

Anti-Trust

Date Filed

February 14, 2020

Featured Stories

Losses Mount For Medicare Drug Negotiation Challengers No Photo Available

Yeji Jesse Lee

Big Pharma's losses in challenges to Medicare drug price negotiations are piling up. But don't think the industry is ready to wave the white flag.

High Court Interest In Health Sharing Ministry Case No Photo Available

Hannah Albarazi

The U.S. Supreme Court is showing interest in a challenge to state regulatory authority over health care sharing ministries. The nonpr... (more story)

Chatbots And Mental Health: Cases And New Laws To Know No Photo Available

Dan McKay

A Texas investigation into the marketing of chatbots as a mental health tool adds to the growing scrutiny on the use of the bots to mi... (more story)